General (Details) - USD ($) $ in Thousands |
1 Months Ended | 12 Months Ended |
|---|---|---|
Oct. 28, 2019 |
Dec. 31, 2021 |
|
| General (Details) [Line Items] | ||
| Recapitalization transaction, percentage | 100.00% | |
| Total consideration from merger (in Dollars) | $ 60,100 | |
| Risk factors, description | Based on the Company’s current cash and commitments, management believes that the Company’s current cash and cash equivalents are sufficient to fund its operations for more than 12 months from the date of issuance of these consolidated financial statements and sufficient to fund its operations necessary to continue development activities. | |
| BiomX Israel [Member] | ||
| General (Details) [Line Items] | ||
| Shareholders total shares (in Shares) | 15,069,058 | |
| Percentage issued to former shareholders of subsidiary in the merger | 65.00% |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Percentage issued to former shareholders of subsidiary in the merger. No definition available.
|
| X | ||||||||||
- Definition Percentage of recapitalization transaction. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|